Ric kayne issues letter to athira shareholders highlighting why immediate board change is required

New york--(business wire)--richard a. (ric) kayne, who together with his affiliates beneficially owns approximately 4.8% of the outstanding shares of common stock of athira pharma, inc. (nasdaq: atha) (“athira” or the “company”), today mailed a letter to athira shareholders outlining the numerous, value destructive missteps by the current board of directors (the “board”), and detailing why immediate change on the board is necessary to restore shareholder value. mr. kayne today also released a v
ATHA Ratings Summary
ATHA Quant Ranking